Curative Biotechnology, Inc. (CUBT)
OTCMKTS · Delayed Price · Currency is USD
0.0071
+0.0010 (16.39%)
Jan 21, 2026, 4:00 PM EST
Curative Biotechnology Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
4
Market Cap
7.51M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2011 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionCurative Biotechnology News
- 19 hours ago - Curative Biotechnology Announces Canadian Patent Allowance - GlobeNewsWire
- 2 months ago - Curative Biotechnology, Inc. Announces Letter to Shareholders - GlobeNewsWire
- 1 year ago - Curative Biotechnology, Inc. Engages Golden Eagle Capital Advisors, Inc. as Exclusive Agent and Strategic Advisor - GlobeNewsWire
- 1 year ago - Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors - GlobeNewsWire
- 2 years ago - Curative Biotechnology, Inc. Announces Nomination of Dr. Jeffrey Liebmann to Board of Directors - GlobeNewsWire
- 2 years ago - Curative Biotechnology Announces Establishment of Japanese Subsidiary for Licensing Transactions and Asset Acquisitions - GlobeNewsWire
- 2 years ago - Curative Biotechnology, Inc. Files Patent on Ophthalmic Formulation - GlobeNewsWire
- 3 years ago - Curative Biotechnology Announces Completion of IND Enabling Reformulated Metformin HCL Eye Drop Study - GlobeNewsWire